|
|
Volumn 10, Issue 5, 2010, Pages 505-506
|
|
Anti-infectives: Current challenges and future perspectives
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2',3' DIDEOXYNUCLEOSIDE DERIVATIVE;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ANTIBIOTIC AGENT;
ANTIFUNGAL AGENT;
ANTIINFECTIVE AGENT;
ANTIRETROVIRUS AGENT;
DAPTOMYCIN;
ECHINOCANDIN;
LINEZOLID;
OXAZOLIDINONE DERIVATIVE;
POLYPEPTIDE ANTIBIOTIC AGENT;
PROTEASOME INHIBITOR;
SMALL INTERFERING RNA;
TRIAZOLE DERIVATIVE;
VANCOMYCIN;
ZIDOVUDINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC SENSITIVITY;
ANTIFUNGAL SUSCEPTIBILITY;
ANTIVIRAL ACTIVITY;
BACTERIAL STRAIN;
DISEASE PREDISPOSITION;
DRUG DESIGN;
DRUG EFFICACY;
DRUG SAFETY;
EDITORIAL;
GENE SEQUENCE;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IN VITRO STUDY;
INFECTION;
INFECTION PREVENTION;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION;
MORTALITY;
NONHUMAN;
POINT MUTATION;
PRIORITY JOURNAL;
PUBLIC HEALTH;
SYSTEMIC MYCOSIS;
VIRUS REPLICATION;
ANTI-INFECTIVE AGENTS;
DRUG RESISTANCE, MICROBIAL;
HIV INFECTIONS;
HUMANS;
MYCOSES;
STAPHYLOCOCCAL INFECTIONS;
|
|
EID: 77956649722
PISSN: 14714892
EISSN: None
Source Type: Journal
DOI: 10.1016/j.coph.2010.07.001 Document Type: Editorial |
|
Times cited : (1)
|
|
References (0)
|
